Not available
Quote | Cidara Therapeutics Inc. (NASDAQ:CDTX)
Last: | $12.915 |
---|---|
Change Percent: | -0.19% |
Open: | $12.51 |
Close: | $12.94 |
High: | $12.99 |
Low: | $12.51 |
Volume: | 2,866 |
Last Trade Date Time: | 07/17/2024 03:00:00 am |
News | Cidara Therapeutics Inc. (NASDAQ:CDTX)
2024-07-16 23:12:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
SAN DIEGO, May 30, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak ® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing serious...
Message Board Posts | Cidara Therapeutics Inc. (NASDAQ:CDTX)
Subject | By | Source | When |
---|---|---|---|
$CDTX Should be up bigly tomorrow. Pres and | MiamiGent | investorshub | 03/28/2023 12:32:15 AM |
$CDTX Just added @ .95 | MiamiGent | investorshub | 03/27/2023 4:27:23 PM |
Interesting announcement by 5AM Ventures..... they | now invest | investorshub | 03/23/2023 2:52:53 PM |
Hello Ed. Also check out $ADRX. That one | enthalpy | investorshub | 03/23/2023 12:47:37 PM |
still losing money but is is narrowing | ed3/6me | investorshub | 03/23/2023 12:00:27 PM |
News, Short Squeeze, Breakout and More Instantly...
Cidara Therapeutics Inc. Company Name:
CDTX Stock Symbol:
NASDAQ Market:
Cidara Therapeutics Inc. Website:
2024-07-16 23:12:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
SAN DIEGO, May 30, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak ® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing serious...
SAN DIEGO, May 15, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX) (the Company), a biotechnology company using its proprietary Cloudbreak ® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients ...